CO

Concentra Group Holdings Parent, Inc.

CONHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$2.16B
+13.9% YoY
Net Income
$166.4M
-0.1% YoY
EBITDA
$408.9M
+11.0% YoY
Free Cash Flow
$204.8M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ RSI OverboughtRSI 70.9, above 70, stock may be overbought
Oct 19▼ RSI OverboughtRSI 74.7, above 70, stock may be overbought
About Concentra Group Holdings Parent, Inc.

Operating under the Medical Care Facilities umbrella, Concentra Group Holdings Parent, Inc. is a healthcare company. Concentra Group Holdings Parent, Inc. With a market capitalization of $5.01B, it sits in mid-cap territory. provides occupational health services in the United States.

Where CON stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, CON finished 30.31% above its 150-day moving average ($29.30) and 38.74% above its 200-day moving average ($27.52). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CON overbought or oversold?

At the October 20, 2026 close, CON's RSI(14) was 70.9, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$5.01B
P/E (TTM)25.32
Fwd P/E21.28
EPS$1.55
Beta0.63
52W Change+87.7%
Dividend Yield0.64%
ROE47.1%
Analysis

The company holds $158.0M in cash, though total debt stands at $2.14B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $204.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 47.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $1.72B (2022) to $2.16B (2025), reflecting a 25% increase over the period.

CON's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Concentra Group Holdings Parent, Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms